University at Buffalo - The State University of New York
Skip to Content
D'Silva NJ[au] - PubMed - NCBI
Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.

de Medeiros MC, Banerjee R, Liu M, Anovazzi G, D'Silva NJ, Junior CR.

Oncotarget. 2017 Jun 15;8(37):60860-60874. doi: 10.18632/oncotarget.18486. eCollection 2017 Sep 22.

2.

Cytokines in saliva increase in head and neck cancer patients after treatment.

Russo N, Bellile E, Murdoch-Kinch CA, Liu M, Eisbruch A, Wolf GT, D'Silva NJ.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Oct;122(4):483-490.e1. doi: 10.1016/j.oooo.2016.05.020. Epub 2016 Jun 9.

3.

CDH11 inhibits proliferation and invasion in head and neck cancer.

Piao S, Inglehart RC, Scanlon CS, Russo N, Banerjee R, D'Silva NJ.

J Oral Pathol Med. 2017 Feb;46(2):89-97. doi: 10.1111/jop.12471. Epub 2016 Jul 10.

PMID:
27397103
4.

Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.

Banerjee R, Russo N, Liu M, Basrur V, Bellile E, Palanisamy N, Scanlon CS, van Tubergen E, Inglehart RC, Metwally T, Mani RS, Yocum A, Nyati MK, Castilho RM, Varambally S, Chinnaiyan AM, D'Silva NJ.

Nat Commun. 2016 Feb 24;7:10726. doi: 10.1038/ncomms10726. No abstract available.

5.

Galanin modulates the neural niche to favour perineural invasion in head and neck cancer.

Scanlon CS, Banerjee R, Inglehart RC, Liu M, Russo N, Hariharan A, van Tubergen EA, Corson SL, Asangani IA, Mistretta CM, Chinnaiyan AM, D'Silva NJ.

Nat Commun. 2015 Apr 28;6:6885. doi: 10.1038/ncomms7885.

6.

Reviewing and reconsidering invasion assays in head and neck cancer.

Inglehart RC, Scanlon CS, D'Silva NJ.

Oral Oncol. 2014 Dec;50(12):1137-43. doi: 10.1016/j.oraloncology.2014.09.010. Epub 2014 Oct 14. Review.

7.

DUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma.

Zhang X, Hyer JM, Yu H, D'Silva NJ, Kirkwood KL.

Cancer Res. 2014 Dec 15;74(24):7191-7. doi: 10.1158/0008-5472.CAN-14-1379. Epub 2014 Oct 13.

8.

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.

Banerjee R, Russo N, Liu M, Basrur V, Bellile E, Palanisamy N, Scanlon CS, van Tubergen E, Inglehart RC, Metwally T, Mani RS, Yocum A, Nyati MK, Castilho RM, Varambally S, Chinnaiyan AM, D'Silva NJ.

Nat Commun. 2014 Jul 31;5:4527. doi: 10.1038/ncomms5527. Erratum in: Nat Commun. 2016;7:10726.

9.

The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.

Banerjee R, Van Tubergen EA, Scanlon CS, Vander Broek R, Lints JP, Liu M, Russo N, Inglehart RC, Wang Y, Polverini PJ, Kirkwood KL, D'Silva NJ.

Mol Cancer Ther. 2014 May;13(5):1323-33. doi: 10.1158/1535-7163.MCT-13-0904. Epub 2014 Feb 25.

10.

Characterization of squamous cell carcinoma in an organotypic culture via subsurface non-linear optical molecular imaging.

Scanlon CS, Van Tubergen EA, Chen LC, Elahi SF, Kuo S, Feinberg S, Mycek MA, D'Silva NJ.

Exp Biol Med (Maywood). 2013 Nov 1;238(11):1233-41. doi: 10.1177/1535370213502628. Epub 2013 Oct 1.

11.

Differential expression of mitogen activating protein kinases in periodontitis.

Travan S, Li F, D'Silva NJ, Slate EH, Kirkwood KL.

J Clin Periodontol. 2013 Aug;40(8):757-64. doi: 10.1111/jcpe.12123. Epub 2013 Jun 7.

12.
13.

The Histone Methyltransferase EZH2 Mediates Tumor Progression on the Chick Chorioallantoic Membrane Assay, a Novel Model of Head and Neck Squamous Cell Carcinoma.

Liu M, Scanlon CS, Banerjee R, Russo N, Inglehart RC, Willis AL, Weiss SJ, D'Silva NJ.

Transl Oncol. 2013 Jun 1;6(3):273-81. Print 2013 Jun.

14.

Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6.

Van Tubergen EA, Banerjee R, Liu M, Vander Broek R, Light E, Kuo S, Feinberg SE, Willis AL, Wolf G, Carey T, Bradford C, Prince M, Worden FP, Kirkwood KL, D'Silva NJ.

Clin Cancer Res. 2013 Mar 1;19(5):1169-79. doi: 10.1158/1078-0432.CCR-12-2927. Epub 2013 Jan 24.

15.

A novel approach to biomarker discovery in head and neck cancer using an autoantibody signature.

Russo N, Wang X, Liu M, Banerjee R, Goto M, Scanlon C, Metwally T, Inglehart RC, Tsodikov A, Duffy S, Van Tubergen E, Bradford C, Carey T, Wolf G, Chinnaiyan AM, D'Silva NJ.

Oncogene. 2013 Oct 17;32(42):5026-37. doi: 10.1038/onc.2012.532. Epub 2012 Nov 19.

16.

Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.

Scanlon CS, Van Tubergen EA, Inglehart RC, D'Silva NJ.

J Dent Res. 2013 Feb;92(2):114-21. doi: 10.1177/0022034512467352. Epub 2012 Nov 5. Review.

17.

Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.

Zhang X, Junior CR, Liu M, Li F, D'Silva NJ, Kirkwood KL.

Oral Oncol. 2013 Feb;49(2):119-28. doi: 10.1016/j.oraloncology.2012.08.004. Epub 2012 Sep 16.

18.

Rap1 and its regulatory proteins: the tumor suppressor, oncogene, tumor suppressor gene axis in head and neck cancer.

Banerjee R, Russo N, Liu M, Van Tubergen E, D'Silva NJ.

Small GTPases. 2012 Jul-Sep;3(3):192-7. doi: 10.4161/sgtp.20413. Epub 2012 Jun 11.

19.

Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis.

Kamarajan P, Alhazzazi TY, Danciu T, D'silva NJ, Verdin E, Kapila YL.

Cancer. 2012 Dec 1;118(23):5800-10. doi: 10.1002/cncr.27655. Epub 2012 Jun 6.

20.

Control of cytokine mRNA expression by RNA-binding proteins and microRNAs.

Palanisamy V, Jakymiw A, Van Tubergen EA, D'Silva NJ, Kirkwood KL.

J Dent Res. 2012 Jul;91(7):651-8. doi: 10.1177/0022034512437372. Epub 2012 Feb 1. Review.

21.

Higher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysis.

Arthur AE, Duffy SA, Sanchez GI, Gruber SB, Terrell JE, Hebert JR, Light E, Bradford CR, D'Silva NJ, Carey TE, Wolf GT, Peterson KE, Rozek LS.

Nutr Cancer. 2011;63(5):734-42. doi: 10.1080/01635581.2011.570894. Epub 2011 Jun 11.

22.

Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.

Van Tubergen E, Vander Broek R, Lee J, Wolf G, Carey T, Bradford C, Prince M, Kirkwood KL, D'Silva NJ.

Cancer. 2011 Jun 15;117(12):2677-89. doi: 10.1002/cncr.25859. Epub 2011 Jan 10.

23.

Bisphosphonates inhibit expression of p63 by oral keratinocytes.

Scheller EL, Baldwin CM, Kuo S, D'Silva NJ, Feinberg SE, Krebsbach PH, Edwards PC.

J Dent Res. 2011 Jul;90(7):894-9. doi: 10.1177/0022034511407918. Epub 2011 May 6.

24.

The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma.

Banerjee R, Mani RS, Russo N, Scanlon CS, Tsodikov A, Jing X, Cao Q, Palanisamy N, Metwally T, Inglehart RC, Tomlins S, Bradford C, Carey T, Wolf G, Kalyana-Sundaram S, Chinnaiyan AM, Varambally S, D'Silva NJ.

Oncogene. 2011 Oct 20;30(42):4339-49. doi: 10.1038/onc.2011.141. Epub 2011 May 2.

25.

Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer.

Alhazzazi TY, Kamarajan P, Joo N, Huang JY, Verdin E, D'Silva NJ, Kapila YL.

Cancer. 2011 Apr 15;117(8):1670-8. doi: 10.1002/cncr.25676. Epub 2010 Nov 29.

26.

Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region.

Zhao W, Liu M, D'Silva NJ, Kirkwood KL.

J Interferon Cytokine Res. 2011 Aug;31(8):629-37. doi: 10.1089/jir.2010.0154. Epub 2011 Apr 3.

27.

Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma.

Banerjee R, Henson BS, Russo N, Tsodikov A, D'Silva NJ.

Cell Signal. 2011 Jul;23(7):1110-8. doi: 10.1016/j.cellsig.2011.02.002. Epub 2011 Feb 21.

28.

Recovery of salivary epidermal growth factor in parotid saliva following parotid sparing radiation therapy: a proof-of-principle study.

Murdoch-Kinch CA, Russo N, Griffith S, Braun T, Eisbruch A, D'Silva NJ.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Jan;111(1):64-70. doi: 10.1016/j.tripleo.2010.09.005.

PMID:
21176822
29.

High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma.

Stanbery L, D'Silva NJ, Lee JS, Bradford CR, Carey TE, Prince ME, Wolf GT, Worden FP, Cordell KG, Petty EM.

Transl Oncol. 2010 Aug 1;3(4):239-45.

30.

Clinical-pathological conference: case 5.

Fowler CB, D'Silva NJ.

Head Neck Pathol. 2010 Sep;4(3):234-7. doi: 10.1007/s12105-010-0194-2. Epub 2010 Jul 30. No abstract available.

31.

The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion.

Kamarajan P, Garcia-Pardo A, D'Silva NJ, Kapila YL.

BMC Cancer. 2010 Jun 25;10:330. doi: 10.1186/1471-2407-10-330.

32.

Analysis of GNAS mutations in cemento-ossifying fibromas and cemento-osseous dysplasias of the jaws.

Patel MM, Wilkey JF, Abdelsayed R, D'Silva NJ, Malchoff C, Mallya SM.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):739-43. doi: 10.1016/j.tripleo.2009.12.016. Epub 2010 Mar 25.

33.

Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent transcription and invasion in squamous cell carcinoma of the head and neck.

Goto M, Mitra RS, Liu M, Lee J, Henson BS, Carey T, Bradford C, Prince M, Wang CY, Fearon ER, D'Silva NJ.

Clin Cancer Res. 2010 Jan 1;16(1):65-76. doi: 10.1158/1078-0432.CCR-09-1122. Epub 2009 Dec 22.

34.

High matrix metalloproteinase activity is a hallmark of periapical granulomas.

de Paula-Silva FW, D'Silva NJ, da Silva LA, Kapila YL.

J Endod. 2009 Sep;35(9):1234-42. doi: 10.1016/j.joen.2009.06.008.

35.

Implant compression necrosis: current understanding and case report.

Bashutski JD, D'Silva NJ, Wang HL.

J Periodontol. 2009 Apr;80(4):700-4. doi: 10.1902/jop.2009.080581. Erratum in: J Periodontol. 2009 Jun;80(6):1018.

PMID:
19335092
36.

Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use.

Chang PC, Cirelli JA, Jin Q, Seol YJ, Sugai JV, D'Silva NJ, Danciu TE, Chandler LA, Sosnowski BA, Giannobile WV.

Hum Gene Ther. 2009 May;20(5):486-96. doi: 10.1089/hum.2008.114.

37.

Adenomatoid odontogenic tumor developing in association with an odontoma: report of a case.

Cudney N, Persico J, Cordell KG, D'Silva NJ.

Quintessence Int. 2008 Sep;39(8):693-7.

PMID:
19107257
38.

Fungiform papilla pattern: EGF regulates inter-papilla lingual epithelium and decreases papilla number by means of PI3K/Akt, MEK/ERK, and p38 MAPK signaling.

Liu HX, Henson BS, Zhou Y, D'Silva NJ, Mistretta CM.

Dev Dyn. 2008 Sep;237(9):2378-93. doi: 10.1002/dvdy.21657.

39.

Targeting mRNA stability arrests inflammatory bone loss.

Patil CS, Liu M, Zhao W, Coatney DD, Li F, VanTubergen EA, D'Silva NJ, Kirkwood KL.

Mol Ther. 2008 Oct;16(10):1657-64. doi: 10.1038/mt.2008.163. Epub 2008 Aug 5.

40.

Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.

Mitra RS, Goto M, Lee JS, Maldonado D, Taylor JM, Pan Q, Carey TE, Bradford CR, Prince ME, Cordell KG, Kirkwood KL, D'Silva NJ.

Cancer Res. 2008 May 15;68(10):3959-69. doi: 10.1158/0008-5472.CAN-07-2755.

41.

Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.

Worden FP, Kumar B, Lee JS, Wolf GT, Cordell KG, Taylor JM, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Tsien CI, D'Silva NJ, Yang K, Kurnit DM, Mason HL, Miller TH, Wallace NE, Bradford CR, Carey TE.

J Clin Oncol. 2008 Jul 1;26(19):3138-46. doi: 10.1200/JCO.2007.12.7597. Epub 2008 May 12.

42.

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.

Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D'Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR, Carey TE.

J Clin Oncol. 2008 Jul 1;26(19):3128-37. doi: 10.1200/JCO.2007.12.7662. Epub 2008 May 12.

43.

Stromal-derived factor-1alpha (CXCL12) levels increase in periodontal disease.

Havens AM, Chiu E, Taba M, Wang J, Shiozawa Y, Jung Y, Taichman LS, D'Silva NJ, Gopalakrishnan R, Wang C, Giannobile WV, Taichman RS.

J Periodontol. 2008 May;79(5):845-53. doi: 10.1902/jop.2008.070514 .

44.

Tissue biomarkers for diagnosis & management of oral squamous cell carcinoma.

D'Silva NJ, Ward BB.

Alpha Omegan. 2007;100(4):182-9. Review.

PMID:
18335816
45.

Soft tissue swelling of the upper lip.

D'Silva NJ, Benian R, Flint A, Cordell KG.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Mar;105(3):271-3. doi: 10.1016/j.tripleo.2007.08.037. No abstract available.

PMID:
18280958
46.

Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking.

Kumar B, Cordell KG, Lee JS, Prince ME, Tran HH, Wolf GT, Urba SG, Worden FP, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D'Silva NJ, Yang K, Kurnit DM, Bradford CR, Carey TE.

Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S109-11.

47.

Mucous membrane pemphigoid: a retrospective study.

Chiou S, Gobetti JP, D'Silva NJ.

J Mich Dent Assoc. 2007 May;89(5):46-52.

PMID:
17564340
48.

An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma.

Henson B, Li F, Coatney DD, Carey TE, Mitra RS, Kirkwood KL, D'Silva NJ.

J Oral Pathol Med. 2007 Jul;36(6):363-70.

49.

Metastatic tumors in the jaws: a retrospective study of 114 cases.

D'Silva NJ, Summerlin DJ, Cordell KG, Abdelsayed RA, Tomich CE, Hanks CT, Fear D, Meyrowitz S.

J Am Dent Assoc. 2006 Dec;137(12):1667-72.

PMID:
17138711
50.

A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.

Kirkwood KL, Li F, Rogers JE, Otremba J, Coatney DD, Kreider JM, D'Silva NJ, Chakravarty S, Dugar S, Higgins LS, Protter AA, Medicherla S.

J Pharmacol Exp Ther. 2007 Jan;320(1):56-63. Epub 2006 Oct 13.

Supplemental Content

Loading ...
Support Center